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Introduction
Postoperative morbidity after colorectal resec-
tions for cancer remains a  significant problem. In 
spite of evolution in operative technique, implemen-
tation of modern perioperative protocols and im-
provements in surgical instruments, postoperative 
complication rates range from 18% to 38% [1–5]. 
The short-term consequences of postoperative mor-
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A b s t r a c t
Introduction: Postoperative morbidity after colorectal resections for cancer remains a significant problem. Data on 
the influence of complications on survival after laparoscopic colorectal resection are still limited.
Aim: To analyze the impact of postoperative complications on long-term survival after radical laparoscopic resection 
for colorectal cancer.
Material and methods: Two hundred and sixty-five consecutive non-metastatic colorectal cancer patients under-
going laparoscopic colorectal resection for cancer were included in the analysis. The entire study group was divided 
into two subgroups based on the occurrence of postoperative complications. Group 1 included patients without post-
operative morbidity and group 2 included patients with complications. The primary outcome was overall survival.
Results: Median follow-up was 45 (IQR: 34–55) months. Group 1 consisted of 187 (70.5%) patients and group 2 com-
prised 78 (29.5%) patients. Studied groups were comparable in terms of sex, age, body mass index, ASA class, cancer 
staging, localization of the tumor and operative time. Patients in group 1 had significantly better overall 3-year survival 
compared to those with complications (84.9% vs. 69.8%, p = 0.022). Kaplan-Meier curves showed significantly improved 
survival rates in patients without complications compared with complicated cases. The Cox proportional multivariate 
model showed that postoperative complications (HR = 2.83; 95% CI: 1.35–5.92; p = 0.0058) and AJCC III (HR = 3.17; 
95% CI: 1.52–6.6; p = 0.0021) were independent predictors of worse survival after laparoscopic colorectal cancer surgery.
Conclusions: Our analysis of interim results after 3 years confirms that complications after laparoscopic colorectal 
cancer surgery have an impact on survival. For this reason, these patients should be carefully monitored after surgery 
aiming at early detection of recurrence.
Key words: laparoscopy, colorectal cancer, survival, postoperative complications.
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bidity are well established: prolonged hospital stay, 
need for surgical reintervention, need for ICU stay 
and increased mortality [6]. This is also accompa-
nied by higher costs of treatment [7]. Moreover, it 
has been shown that postoperative complications 
may delay chemotherapy, which influences the qual-
ity of oncologic management [8–10]. There are also 
reports showing that postoperative morbidity might 
affect long-term survival [11]. However, the majority 
of them include patients undergoing open or a mix 
of open and laparoscopic surgery [12]. Data on the 
influence of complications on survival after laparo-
scopic colorectal resection are still limited. 
Aim
The aim of our study was to analyze the impact 
of postoperative complications on long-term surviv-
al after radical laparoscopic resection for colorectal 
cancer. 
Material and methods
Consecutive colorectal cancer patients undergo-
ing laparoscopic colorectal resection for cancer be-
tween 2013 and 2016 were included in the prospec-
tively collected database. Inclusion criteria for our 
study were: age over 18 years, histopathologically 
confirmed adenocarcinoma of the colon or rectum, 
laparoscopic approach, and patients with at least 
2-year follow-up. Exclusion criteria included emer-
gency or initially open surgery, transanal endoscop-
ic microsurgery, concomitant inflammatory bowel 
diseases, patients with stage IV cancer according to 
AJCC classification diagnosed before primary surgery, 
and patients who died within 30 days of surgery. 
The standard surgical procedure was laparoscop-
ic resection combined with the well-established 
ERAS protocol [13–15]. When appropriate, patients 
with rectal cancer underwent preoperative radio- or 
chemoradiotherapy. All patients were discussed post-
operatively during a  multidisciplinary team meet-
ing and adjuvant chemotherapy was administered 
according to the most recent guidelines. Figure 1 
presents the patients’ flow through the study.
Outcome measures
The entire study group was divided into two 
subgroups based on the occurrence of postopera-
tive complications. Group 1 included patients with-
out postoperative morbidity and group 2 included 
patients with complications. They were graded ac-
cording to the Clavien-Dindo classification [16, 17]. 
When a patient developed more than one complica-
tion, the most severe one was used for analysis. The 
primary outcome was overall survival. Other out-
comes included the following measures: differences 
in survival according to severity of complications 
and stage of cancer.
Material
The study group included 265 patients with me-
dian 45 (IQR: 34–55) months follow-up. Group 1 con-
sisted of 187 (70.5%) patients without complications 
and group 2 comprised 78 (29.5%) patients with at 
least one complication. Table 1 presents their severity 
according to the Clavien-Dindo classification. There 
were no differences between groups in terms of basic 
demographic parameters: sex, age, body mass index 
(BMI), ASA class. There was also no difference in type 
of surgery (colon/rectum) or operative time (median: 
180 min). However, we noted a statistically significant 
difference in intraoperative blood loss (50 vs. 100 ml, 
p = 0.0352). Cancer staging was not different be-
tween the groups (Table I). 
Ethical approval
The study was approved by the local Ethics Review 
Committee (approval number 1072.6120.225.2017). 
All procedures were performed in accordance with 
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Figure 1. Kaplan-Meier curves of overall survival 
according to presence of complications
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the ethical standards laid down in the 1964 Declara-
tion of Helsinki and its later amendments. 
Statistical analysis
All data were analyzed with StatSoft Statisti-
ca v.13. The results are presented as mean ± stan-
dard deviation (SD), median and interquartile range 
(IQR) and hazard ratio (HR) with 95% confidence 
intervals (CI) when appropriate. The study of cate-
gorical variables used the c2 test of independence. 
The Shapiro-Wilk test was used to check for nor-
mal distribution of data and Student’s t-test was 
used for normally distributed quantitative data. For 
non-normally distributed quantitative variables, the 
Mann-Whitney U  test was used. For the purposes 
of further analysis, the entire group of patients was 
divided into subgroups depending on occurrence of 
complications. Survival data were analyzed accord-
ing to the Kaplan-Meier method. The log-rank test 
was used to detect differences between groups. Uni-
variate and multivariate analysis was performed us-
ing Cox proportional hazards.
Variables for which p < 0.05 were included in the 
model. Results were considered statistically signifi-
cant when the p-value was found to be less than 0.05.
Table I. Demographic analysis of patient groups
Parameter Group 1
Non-complicated
Group 2  
Complicated
P-value
Basic demographic parameters:
Number of patients, n (%) 187 (70.6) 78 (29.4) –
Females, n (%) 93 (49.7) 34 (43.6) 0.3617
Males, n (%) 94 (50.3) 44 (56.4)
Age, mean ± SD [years] 65.3 ±13.4 64.1 ±13.1 0.4269
BMI, mean ± SD [kg/m2] 26.6 ±4.9 26.1 ±4.3 0.7455
ASA 1, n (%) 10 (5.3) – 0.0586
ASA 2, n (%) 107 (57.2) 56 (71.8)
ASA 3, n (%) 66 (35.3) 21 (26.9)
ASA 4, n (%) 4 (2.1) 1 (1.28)
Operative parameters:
Operative time, median (IQR) [min] 180 (150–240) 180 (160–235) 0.4729
Intraoperative blood loss, median (IQR) [ml] 50 (50–150) 100 (50–200) 0.0352
Colon, n (%) 129 (68.9) 46 (59.9) 0.1198
Rectum, n (%) 58 (31.1) 32 (41.1)
Stage of cancer, n (%):
AJCC stage I 79 (42.2) 30 (38.4) 0.5327
AJCC stage II 63 (33.7) 24 (30.8)
AJCC stage III 45 (24.1) 24 (30.8)
Postoperative complications, n (%):
Clavien-Dindo I 35 (13.2)
Clavien-Dindo II 17 (6.4)
Clavien-Dindo III 19 (7.2)
Clavien-Dindo IV 7 (2.6)
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Results
When analyzing survival, we noted that patients 
without complications had significantly better over-
all 3-year survival compared to those with complica-
tions (84.9% vs. 69.8%, p = 0.022). Figure 1 shows 
Kaplan-Meier curves of overall survival according to 
presence of complications. 
Patients without complications showed sig-
nificantly improved survival rates compared with 
complicated patients, p = 0.00166 (log-rank test for 
equality of survival functions).
Subsequent analysis of subgroups revealed that 
patients with severe complications (Clavien-Dindo 
III–IV) did not differ from those with less severe mor-
bidity (Clavien-Dindo I–II) (Figure 2). 
The Cox proportional multivariate model showed 
that postoperative complications (HR = 2.83; 95% CI: 
1.35–5.92; p = 0.0058) and AJCC III (HR = 3.17; 95% CI: 
1.52–6.6; p = 0.0021) were independent predictors 
of worse survival after laparoscopic colorectal cancer 
surgery. 
Discussion
This interim analysis of outcomes confirmed the 
association between postoperative complications 
and worse long-term overall survival after laparo-
scopic resection for non-metastatic bowel cancer. 
Patients who developed at least one complication 
had significantly lower 3-year survival compared to 
uncomplicated cases. Moreover, we did not note any 
difference in survival related to severity of postop-
erative complications – patients with Clavien-Dindo 
1–2 complications had similar outcomes to those 
with Clavien-Dindo 3–4 complications. 
More than 25 years after introduction to colorec-
tal surgery the general attitude towards laparoscopy 
has evolved. In the past it was considered inferior 
to the open approach, leading to worse oncologic 
outcomes [18, 19]. However, the most recent anal-
yses confirm the safety of laparoscopy, which is not 
inferior to open access surgery in terms of short- 
and long-term results [20, 21]. In the conclusions 
of a  systematic review comparing open and lapa-
roscopic approach to colonic cancer, Di et al. stat-
ed that the apparent advantages of laparoscopy in 
short-term outcomes suggest that it should be wide-
ly recommended in clinical practice [20]. This could 
be attributed to the potential reduction in peri- and 
post-operative morbidity associated with minimal-
ly invasive surgery. Interestingly, the most recently 
published randomized controlled trials covering this 
topic in rectal cancer surgery did not reveal differ-
ences in morbidity [21]. In contrast, registry analyses 
of large cohorts of patients clearly demonstrate ben-
efits of minimally invasive access. Registries may be 
blamed for selection bias, but even randomized tri-
als leave some space for criticism related to the spe-
cific limitations typical for this type of studies. On 
one hand they are prone to the Hawthorne effect, 
while on the other hand they usually show results of 
carefully selected high-volume centers, which may 
be different from the results at a national level. In 
addition, their inclusion criteria are often different 
from clinical characteristics of cancer patients in the 
general population. 
The complication rate in our cohort was 29.4%. 
This is in line with previously published reports 
[22–24]. Since 2013 the Enhanced Recovery After 
Surgery Protocol has been a standard of care in our 
institution and all patients included in the analysis 
were treated according to the ERAS protocol. This 
perioperative strategy is becoming the gold standard 
in care of patients submitted to surgery. Previous 
studies confirmed that application of ERAS shortens 
the length of stay and diminishes morbidity [25–27]. 
For instance, in colorectal surgery it has been shown 
to significantly improve outcomes by reduction of 
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Figure 2. Kaplan-Meier curves of overall survival 
according to presence of complications and their 
severity (log-rank test forequality of survival func-
tions)
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postoperative morbidity (mainly non-surgical) by up 
to 40% [28, 29].
Careful analysis of cases showed significant-
ly worse long-term survival after laparoscopic col-
orectal resection with complications Several factors 
might have contributed to this phenomenon. First-
ly, complications postpone introduction of adjuvant 
chemotherapy. This is perhaps the strongest factor 
leading to inferior outcomes in group 2 (complicat-
ed). Several reports showed that delay in chemother-
apy results in lower survival [30]. Moreover, even if 
chemotherapy was administered within the window 
of opportunity, patients with complications still pre-
sented with worse survival [30, 31]. It has also been 
confirmed that chemotherapy after laparoscopic re-
section may be introduced earlier than after the open 
approach [30, 32, 33]. However, patients in our co-
hort had worse outcomes regardless of the severity 
of complications. Therefore, another explanation is 
needed requiring more profound studies of the role 
of infectious and inflammatory processes and the 
impact of the immune system influencing long-term 
survival among complicated patients [34–37]. Post-
operative immunosuppression is certainly greater in 
patients with complications or after more severe sur-
gical trauma (open surgery). Previous studies found 
a link between the immune response and cancer re-
currence [6, 38–40]. Another factor to include is the 
adrenal response to stress and infection [41, 42]. Both 
these factors have been shown to increase cortisol 
levels. There is evidence for an association between 
cortisol levels, stress, depression and development of 
metastases in other malignancies but a causative re-
lationship still has not been documented [43, 44]. All 
those factors – apart from delay in chemotherapy– 
may have an influence on survival rates in patients 
with a complicated postoperative course.
Our study has several limitations. In this analy-
sis we assessed only overall 3-year survival. For this 
reason, these are interim results rather than a  full 
analysis of outcomes. The number of patients with 
complete 5-year observation was lower, so we de-
cided to shorten the observation period in order to 
increase the number of individuals in the group and 
achieve meaningful results. We also measured only 
overall, not cancer-specific survival, which might 
also give biased results. When analyzing survival, 
we used the national personal identification num-
ber database (PESEL), which provides information 
on the date of death but not its cause. However, we 
believe that overall survival is the most important 
benchmark from the point of view of both clinicians 
and patients. Another limitation is the lack of precise 
data about type of adjuvant therapy regimens and 
treatment protocol compliance in our patients who 
received this chemotherapy in various institutions 
with potentially different standards of follow-up.
In our study colonic and rectal cases are dis-
cussed together, potentially leading to some bias 
due to different levels of complexity of surgery. How-
ever, it has been shown that in ERAS and laparoscopy 
environment, colonic and rectal resections provide 
similar outcomes in terms of short-term measures 
and morbidity [14]. Additionally, the composition of 
our cohort (approx. 40% rectal cancer patients and 
60% colon cancer patients) is similar to general ep-
idemiology of colon and rectum cancer in western 
populations. Therefore, we would argue that our co-
hort was representative. 
Conclusions
Postoperative complications after laparoscopic 
colorectal cancer surgery have a significant impact 
on long-term outcomes. For this reason, these pa-
tients should be carefully monitored after surgery, 
aiming at early detection of recurrence. 
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